Neuphoria Therapeutics (NEUP) Current Assets (2021 - 2026)
Neuphoria Therapeutics' Current Assets came in at $21.07 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 40.1% from $15.04 million a year earlier but down 2.7% from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Current Assets (2021 - 2026) Analysis & Trends
Going back to fiscal Q4 2021, Neuphoria Therapeutics' Current Assets data covers 12 quarters.
- Current Assets carries a five-year compound annual growth rate of -2.4% (FY2021 to FY2026).
- Going back by fiscal year, Current Assets was $15.04 million in FY2025 (+14.0%), $13.19 million in FY2024 (-1.0%), $13.33 million in FY2023 (-55.5%) and $29.95 million in FY2022 (+25.7%).
- The five-year range for quarterly Current Assets is $4.4 million (fiscal Q2 2025) to $29.95 million (fiscal Q4 2022).
- Year-over-year, Current Assets has increased for five consecutive quarters, with growth averaging 115.6% over the last five quarters.
- The fastest year-over-year change in Current Assets over five years came in fiscal Q2 2026 (growth of 431.7%), and the weakest in fiscal Q4 2023 (a decline of 55.2%).
- Business Quant data shows NEUP's Current Assets at $21.66 million (Q3 2026), $23.39 million (Q2 2026) and $13.95 million (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Neuphoria Therapeutics | 443.79 Mn | 368.60 Mn | - | 21.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.07 Mn |
| Mar 31, 2026 | 21.66 Mn |
| Dec 31, 2025 | 23.39 Mn |
| Sep 30, 2025 | 13.95 Mn |
| Jun 30, 2025 | 15.04 Mn |
| Mar 31, 2025 | 17.09 Mn |
| Dec 31, 2024 | 4.40 Mn |
| Sep 30, 2024 | 8.43 Mn |
| Jun 30, 2024 | 13.19 Mn |
| Jun 30, 2023 | 13.43 Mn |
| Jun 30, 2022 | 29.95 Mn |
| Jun 30, 2021 | 23.82 Mn |
API Access
Neuphoria Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();